In order to better understand the underlying molecular mechanisms causing GALC dysfunction in Krabbe disease, clinically relevant variants of GALC were expressed in cells and monitored for their capacity to traffic beyond the ER‐TGN and to localize to their site of action in lysosomes. Here, GALC is linked to Krabbe disease.